Rush venom immunotherapy: a 3-day programme for hymenoptera sting allergy

Area of Science:

• Allergy and Immunology
• Toxicology

Background:

• Hymenoptera stings can cause severe allergic reactions.
• Traditional immunotherapy protocols can be lengthy.

Purpose of the Study:

• To evaluate the safety and efficacy of a rush immunotherapy protocol for hymenoptera sting allergies.
• To assess patient tolerance and clinical outcomes of rapid venom immunotherapy.

Main Methods:

• A cohort of 52 patients with severe systemic reactions to hymenoptera stings underwent rush immunotherapy.
• The protocol involved reaching a maintenance dose of 100 micrograms of venom within 3 days.
• Patient tolerance, side effects, and clinical effectiveness were monitored.

Main Results:

• The rush immunotherapy protocol was well-tolerated, with no serious side effects reported.
• All patients completed the immunotherapy without interruption.
• Clinical effectiveness was high, with no adverse reactions in patients subsequently stung naturally or via induced sting.
• Elevated IgG antivenom antibody levels were observed consistently from the first month.

Conclusions:

• Rush immunotherapy is a safe and effective treatment for patients allergic to hymenoptera stings.
• This rapid protocol offers a viable alternative for patients requiring venom immunotherapy.
• The method demonstrates excellent clinical outcomes and immunological responses.